medigraphic.com
ISSN 0001-0944 (Print)
Órgano Oficial de la Asociación Dental Mexicana

2006, Number 4

<< Back Next >>

Rev ADM 2006; 63 (4)

Immunologic aspects of the periodontal disease in pediatric patients with down syndrome

Díaz RL, López MPM

Language: Spanish
References: 26
Page: 125-130
PDF size: 190.85 Kb.


ABSTRACT

The periodontal disease in children with Down’s Syndrome (DS) is developed in early stages and it increases progressively with age. There are many factors that contribute to progress of the periodontopathics: local factors, capillary morphology, and connective tissue disorders. Nowadays, the biggest prevalence in the disease is related to the immunologic system, which is unable to control the bacterial invasion for defect defense in the cellular elements, as well as in the regulation of enzymes. For such a reason, it is important that the dentist knows all the factors that intervene in the appearance of the periodontal disease in children with DS.


REFERENCES

  1. Lindhe J. Periodoncia clínica e implantología odontológica. Editorial Médica Panamericana, 3ª edición, Madrid, 2000: 208-220.

  2. Kroll R. Incidence of dental caries and periodontal disease in Down’s syndrome. NYS Dent J 1970; 36: 151-156.

  3. Keyes DM. Study on the pathogenesis of destructive lesions with Down´s syndrome. Clin Pediat 1971; 10: 711-718.

  4. Agholme MB, Dahllof G, Modéer T. Changes of periodontal status in patients with Down’s syndrome during a 7 years period. Eur J Oral Sci 1999; 107: 82-88.

  5. Swallow JN. Dental disease in children with Down’s syndrome. J Ment Defic Res 1964; 8: 102-118.

  6. Brown RH, Cunningham WM. Some dental manifestations of mongolism. Oral Surg, Oral Med, Oral Pathol 1961; 14: 664-76.

  7. Cohen M, Winer R. Dental and facial characteristic in Down´s Syndrome. J Dent Res 1965; 44: 197-207.

  8. Hernández PJ, Tello HJ, Ochoa RG. Alteraciones bucales en niños con síndrome de Down en el estado de Yucatán. ADM 1998; LV: 91-96.

  9. García BC, Esteva CT, Pérez FD, Bermejo CM, Pérez L. Programas preventivos de la enfermedad periodontal en la trisomía 21. Rev Actual de Estomatol 1986; 46: 31-7.

  10. López P, López P, Borges SA, Parés G, Valdespino. Gingivitis en una comunidad infantil mexicana con trisomía 21. División de Estudios de Postgrado e Investigación, F O, UNAM 2000; 11: 5-13.

  11. Reuland BW, Dijk LJ. Periodontal disease in Down´s syndrome: A review. J Clin Periodontol 1986; 13: 64-7.3

  12. Barrios MG. Odontología su fundamento biológico. Editorial Iatros, Colombia, 1991: 744-745.

  13. Seymour A, Robin M, Heasman M. Drugs, disease, and the periodontium. Medical Publications, Oxford, 1992: 170.

  14. Amano A, Kimura S, Takiguchi M. Periodontopathic bacteria in children with Down’s syndrome. J Periodontal 2000; 71: 249-55.

  15. Amano A, Tetsuhiko K, Shigehisa A, Ichiro N. Relationship of periodontopathic bacteria with early-onset periodontitis in Down’s syndrome. Periodontol 2001; 72: 368-363.

  16. Bismteim E. Periodontal and gingival health and diseases: children, adolescent, and young adults. Editorial Martin Dunitz, London, 2001: 289.

  17. Pueschel SM, Pueschel JK. Síndrome de Down problemática biomédica. Fundación Síndrome de Down de Cantabria. Barcelona: Masson-Salvat Mexicana. 1994: 235-244

  18. Nancy J. Down syndrome and associated medical disorders Research Reviews 1996; 2: 85-89.

  19. Levin S. El sistema immune y la susceptibilidad frente a las infecciones en el síndrome de Down. Clin Bio Res 1987; 246: 461-468.

  20. Izumi Y, Sugiyama S, Shinozuka O, Yamazaki T, Ohyama T, Ishikawa I. Defective neutrophil chemotaxis in Down’s syndrome patients and its relationship to periodontal destruction. J Periodontol 1989; 60: 238-42.

  21. Reulan-Bosman W, Van Dijk J, Rozeboom T, Peppema S. Experimental gingivitis in Down’s Syndrome child and sibling. J Clin Microbiol 1987: 949-95.

  22. Sreedevi H, Munshi AK. Neutrophil Chemotaxis in Down syndrome and normal children to actinobacillus actinomycetemcomitans. J Clin Pediatr Dent 1998; 22: 141-146.

  23. Hodge D, Michalowicz B. Genetic predisposition to periodontitis in children and young adults. Periodontology 2000 2001; 26: 113-114.

  24. Halinen S, Sorsa T, Ding Y, Ingman T, Salo T, Konttinen YT, Saari H. Characterization of matrix metalloproteinase (MMP-8 and 9), activities in the saliva and gingival crevicular fluid of children with Down’s syndrome. J Periodontol 1996; 67: 748-754.

  25. Barr AM, Krekmanova L, Yucel-Lindberg T, Shinoda K, Modeer T. Prostaglandin E2 level in gingival crevicular fluid from patients with Down’s syndrome. Acta Odontol Scand 1997; 55: 101-105.

  26. Otsuka Y, Ito M, Yamagichi M, Saito S. Enhancement of lipopolysaccharide stimulated cycloxygenase-2m RNA expression and prostaglandin E2 production in gingival fibroblasts from individuals with down’s syndrome. Mechanisms of ageing and development 2002; 123: 663-6.




2020     |     www.medigraphic.com